Skip to main content
Indofarma Tbk. logo

Indofarma Tbk. — Investor Relations & Filings

Ticker · INAF ISIN · ID1000068406 IDX Manufacturing
Open in API
Filings indexed 11 across all filing types
Latest filing 2026-05-22 Board/Management Inform…
Country ID Indonesia
Listing IDX INAF

About Indofarma Tbk.

https://indofarma.id/

Indofarma, established in 1918, is a pharmaceutical and medical device company. It manufactures and sells a range of products including generic and branded drugs, natural extracts, and diagnostic items for domestic and international markets. The company also provides specialized services such as pharmaceutical and natural extract toll manufacturing, and equivalence testing through its laboratory. With an extensive distribution network, Indofarma supports national health programs by focusing on the supply of essential medicines and medical solutions.

Recent filings

Filing Released Lang Actions
Perubahan Internal Audit
Board/Management Information Classification · 80% confidence The document is a short announcement from Indofarma Tbk. notifying a change in the head of the internal audit unit effective February 9, 2026. It does not contain financial data or voting results, nor is it a report publication notice. It is an announcement of a change in company management personnel. The appropriate category for changes in senior management or internal leadership roles is Board/Management Information (MANG).
2026-05-22 Indonesian
Penyampaian Bukti Iklan Pemberitahuan RUPS
Report Publication Announcement Classification · 87% confidence The document is a brief regulatory announcement from Indofarma Tbk. certifying that the Notice of Annual General Meeting (RUPS) has been published in various media and attaches proof of publication. It does not contain the meeting materials or voting results themselves but simply announces that the notice was issued. Under the “menu vs meal” rule, this is not the AGM notice content itself but an announcement of its publication. Therefore, it is a Report Publication Announcement (RPA).
2026-05-21 Indonesian
Pemberitahuan Rencana Rapat Umum Pemegang Saham Tahunan
Regulatory Filings Classification · 85% confidence The document is a formal notice announcing the planning and scheduling of the Annual General Meeting of Shareholders, listing date, time, location, and record date. It contains no financial data, resolutions, or materials that would make it an AGM presentation (AGM-R), proxy statement (PSI), or any other specific report type. This type of meeting notice falls under general regulatory announcements, so it is best classified as a Regulatory Filing (RNS).
2026-05-19 Indonesian
Laporan Bulanan Registrasi Pemegang Efek
Regulatory Filings Classification · 87% confidence The document is a Monthly Report of Securities Holders Registration (Laporan Bulanan Registrasi Pemegang Efek) for Indofarma Tbk. It provides detailed tables of shareholdings by director/commissioner, >5% holders, public, free float, and classification of investors—i.e., a recurring regulatory disclosure rather than a one-off major shareholding threshold crossing. It is not an annual or interim financial report, nor an earnings release, nor director dealing notice. It is a periodic compliance filing required by the exchange. Therefore it falls under the general Regulatory Filings (RNS) category.
2026-05-09 Indonesian
INAF - FY 2020 - 0862 -S Penyampaian LK kepada OJK 2020.pdf
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Head of Capital Market Supervisory at the Financial Services Authority (Otoritas Jasa Keuangan) in Indonesia, dated April 26, 2021. It states the submission of the Consolidated Financial Statements of PT Indofarma Tbk and its subsidiaries as of December 31, 2020, including the Independent Auditor's Report. The document is short (1386 characters) and serves as a cover letter transmitting the audited financial statements rather than containing the full financial report itself. According to the 'Menu vs Meal' rule, such a document is an announcement or submission notice of a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for such filings that do not contain the full report or detailed financial data.
2020-12-31 Indonesian
INAF - FY 2020 - instance.zip
Regulatory Filings
2020-12-31 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.